search
Back to results

The Children's Amalgam Trial

Primary Purpose

Dental Caries

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Dispersed phase amalgam restoration /composite restoration
Sponsored by
Carelon Research
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries

Eligibility Criteria

6 Years - 10 Years (Child)All SexesDoes not accept healthy volunteers

6 - 10 years of age at last birthday Fluent in English No prior or existing amalgam restorations Two or more posterior teeth with dental caries such that restoration would include the occlusal surfaces No clinical evidence of existing psychological, behavioral, neurologic, immunosuppressive, or renal disorders.

Sites / Locations

  • New England Research Institute

Outcomes

Primary Outcome Measures

IQ as measured by the WISC III Test

Secondary Outcome Measures

Full Information

First Posted
August 1, 2003
Last Updated
April 27, 2010
Sponsor
Carelon Research
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)
search

1. Study Identification

Unique Protocol Identification Number
NCT00065988
Brief Title
The Children's Amalgam Trial
Official Title
Health Effects of Dental Amalgams in Children
Study Type
Interventional

2. Study Status

Record Verification Date
August 2005
Overall Recruitment Status
Completed
Study Start Date
September 1997 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2005 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Carelon Research
Collaborators
National Institute of Dental and Craniofacial Research (NIDCR)

4. Oversight

5. Study Description

Brief Summary
The Children's Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.
Detailed Description
The safety of silver amalgam as a dental restorative material has been controversial since its introduction 150 years ago, but until recently it has been assumed that the exposure to mercury from dental amalgam is limited to the acute placement phase. However, some recent studies have raised safety concerns by demonstrating chronic release of mercury vapor from amalgam fillings during chewing and brushing. The Children's Amalgam Trial (CAT) is a two-arm randomized trial of safety, comparing amalgam with a mercury-free restorative material. A single masking procedure is used to ensure that all investigators and staff measuring outcomes are unaware of assigned trial arm. The study follows 534 New England children, aged 6-10 years at enrollment, for 5 years. The children were recruited from two northeastern U.S. communities, one in rural Maine, and one in urban Massachusetts. No trial subjects received prior amalgam restorations, and all were in need of at least two posterior occlusal fillings. Participants were randomized to receive either amalgam or composite material for all posterior restorations at baseline and at subsequent visits. The primary endpoint will be 5-year change in IQ scores. Secondary endpoints will include measures of other neuropsychological assessments and renal functioning.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Randomized
Enrollment
534 (false)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
Dispersed phase amalgam restoration /composite restoration
Primary Outcome Measure Information:
Title
IQ as measured by the WISC III Test

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
6 - 10 years of age at last birthday Fluent in English No prior or existing amalgam restorations Two or more posterior teeth with dental caries such that restoration would include the occlusal surfaces No clinical evidence of existing psychological, behavioral, neurologic, immunosuppressive, or renal disorders.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sonja M McKinlay
Organizational Affiliation
New England Research Institutes, Inc
Official's Role
Principal Investigator
Facility Information:
Facility Name
New England Research Institute
City
Watertown
State/Province
Massachusetts
ZIP/Postal Code
02472
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
16622139
Citation
Bellinger DC, Trachtenberg F, Barregard L, Tavares M, Cernichiari E, Daniel D, McKinlay S. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA. 2006 Apr 19;295(15):1775-83. doi: 10.1001/jama.295.15.1775.
Results Reference
result
PubMed Identifier
24457893
Citation
Trachtenberg FL, Shrader P, Barregard L, Maserejian NN. Dental composite materials and renal function in children. Br Dent J. 2014 Jan;216(2):E4. doi: 10.1038/sj.bdj.2014.36.
Results Reference
derived
PubMed Identifier
22972857
Citation
Maserejian NN, Hauser R, Tavares M, Trachtenberg FL, Shrader P, McKinlay S. Dental composites and amalgam and physical development in children. J Dent Res. 2012 Nov;91(11):1019-25. doi: 10.1177/0022034512458691. Epub 2012 Sep 12.
Results Reference
derived
PubMed Identifier
22906860
Citation
Maserejian NN, Trachtenberg FL, Hauser R, McKinlay S, Shrader P, Bellinger DC. Dental composite restorations and neuropsychological development in children: treatment level analysis from a randomized clinical trial. Neurotoxicology. 2012 Oct;33(5):1291-7. doi: 10.1016/j.neuro.2012.08.001. Epub 2012 Aug 14.
Results Reference
derived
PubMed Identifier
22802599
Citation
Maserejian NN, Trachtenberg FL, Hauser R, McKinlay S, Shrader P, Tavares M, Bellinger DC. Dental composite restorations and psychosocial function in children. Pediatrics. 2012 Aug;130(2):e328-38. doi: 10.1542/peds.2011-3374. Epub 2012 Jul 16.
Results Reference
derived
PubMed Identifier
20560801
Citation
Trachtenberg F, Barregard L. Effect of storage time at -20 degrees C on markers used for assessment of renal damage in children: albumin, gamma-glutamyl transpeptidase, N-acetyl-beta-D-glucosaminidase and alpha1-microglobulin. Scand J Urol Nephrol. 2010 Nov;44(5):331-6. doi: 10.3109/00365599.2010.492785. Epub 2010 Jun 21.
Results Reference
derived
PubMed Identifier
19329464
Citation
Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. doi: 10.1177/0022034508330884.
Results Reference
derived
PubMed Identifier
18248343
Citation
Maserejian NN, Trachtenberg F, Link C, Tavares M. Underutilization of dental care when it is freely available: a prospective study of the New England Children's Amalgam Trial. J Public Health Dent. 2008 Summer;68(3):139-48. doi: 10.1111/j.1752-7325.2007.00074.x.
Results Reference
derived
PubMed Identifier
17545265
Citation
Soncini JA, Maserejian NN, Trachtenberg F, Tavares M, Hayes C. The longevity of amalgam versus compomer/composite restorations in posterior primary and permanent teeth: findings From the New England Children's Amalgam Trial. J Am Dent Assoc. 2007 Jun;138(6):763-72. doi: 10.14219/jada.archive.2007.0264.
Results Reference
derived

Learn more about this trial

The Children's Amalgam Trial

We'll reach out to this number within 24 hrs